Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 12 March 2020 to Question 26807 on Diabetes: Medical Equipment, what (a) national and (b) regional data NHS England and NHS Improvement hold on the prescription of flash glucose monitors by primary care providers.
The information requested is shown in the following table.
Flash Glucose Monitoring Patient Numbers – Q3 2019/20
Number of Identified Patients with Prescriptions | |||||||
|
| Q1 Uptake | Q2 Uptake | Q3 Uptake | |||
Region | Estimated # of Type 1 patients in the region | # | % | # | % | # | % |
North West | 30,630 | 6,084 | 20 | 7,836 | 26 | 9,325 | 30 |
North East and Yorkshire | 40,490 | 989 | 2 | 5,672 | 14 | 8,640 | 21 |
Midlands | 46,455 | 6,109 | 13 | 8,849 | 19 | 11,534 | 25 |
East | 29,635 | 1,493 | 5 | 3,127 | 11 | 4,633 | 16 |
London | 29,565 | 3,382 | 11 | 4,574 | 15 | 5,975 | 20 |
South West | 26,875 | 4,171 | 16 | 5,748 | 21 | 6,924 | 26 |
South East | 39,275 | 6,231 | 16 | 8,530 | 22 | 10,751 | 27 |
England | 242,925 | 28,459 | 12 | 44,336 | 18 | 57,782 | 24 |
Source: NHS Business Services Authority
Notes:
- These figures represent patient numbers in receipt of flash in primary care.
- Flash Glucose Monitoring uptake has increased markedly in all regions – national uptake is now 24% of all type 1 patients.
- Figures only correspond to individual identified patients with clinical commissioning group prescriptions and may therefore understate full coverage.
Estimated number of type 1 patients sourced from National Diabetes Audit 2017/18